Showing posts with label compliance. Show all posts
Showing posts with label compliance. Show all posts

Tuesday, May 22, 2012

Animal Welfare Act

The Animal Welfare Act (Laboratory Animal Welfare Act of 1966, P.L. 89-544) was signed into law by President Lyndon B. Johnson on August 24, 1966.[1] It is the only Federal law in the United States that regulates the treatment of animals in research and exhibition. Other laws, policies, and guidelines may include additional species coverage or specifications for animal care and use, but all refer to the Animal Welfare Act (otherwise known as the "AWA") as the minimally acceptable standard for animal treatment and care. The USDA and APHIS oversee the AWA and the House and Senate Agriculture Committees have primary legislative jurisdiction over the Act. Animals covered under this Act include any live or dead cat, dog, hamster, rabbit, nonhuman primate, guinea pig, and any other warm-blooded animal determined by the Secretary of Agriculture for research, pet use or exhibition.[2]

As enacted in 1966, the AWA required all animal dealers to be registered and licensed as well as liable to monitoring by Federal regulators and suspension of their license if they violate any provisions of the Animal Welfare Act and imprisonment of up to a year accompanied by a fine of $1,000.[1] All facilities covered by the Animal Welfare Act were required to establish a specialized committee that included at least one person trained as a veterinarian and one not affiliated with the facility. Such committees were to regularly assess animal care, treatment, and practices during research, and were required to inspect all animal study areas at least twice a year. The committees were also required to ensure that alternatives to animal use in experimentation would be used whenever possible.

Although hygienic living conditions were necessary for animals not during experimentation to prevent unintentional infection, there were no such provisions against intentionally infecting animal subjects with disease for the purpose of the experiment.

Research facilities are those that use animals for teaching, experimentation, surgery, or testing purposes. Research facilities must be registered, and include state and local government-run research laboratories, universities, and colleges, diagnostic laboratories, and pharmaceutical firms. Federal facilities, elementary and secondary schools, and agricultural research institutions are among those exempt from registration. AWA requires researchers to provide anesthesia or pain-relieving medication to minimize the pain or distress caused by the experiment

Exclusions

There is much debate as to the actual definition of an animal, but for the purpose of AWA, birds, rats, mice, horses, and other farm animals were excluded from its protection as initially legislated in 1966.[1] The most commonly used animals in laboratories are rats and mice, and therefore they were not regulated in the original law. Purpose-bred rats of the genus Rattus and mice of the genus Mus are not covered by the Animal Welfare Act, but are regulated under PHS policy which applies only to research receiving federal funding from certain federal agencies, including the NIH. These are not federal laws but conditions of funding.

Certain conditions are also excluded from coverage by AWA. Animals that are killed prior to usage, such as frogs used in a biology class, are also not included, so long as they are killed humanely.

Facilities that do not receive Federal funding, such as bear armories, were also not covered by the Act.

The act was amended to include all warmblooded animals in 1970.

http://en.wikipedia.org/wiki/Animal_Welfare_Act_of_1966

Sunday, May 20, 2012

The Common Rule


The Common Rule is a rule of ethics regarding biomedical and behavioral research involving human subjects in the United States. These regulations governing Institutional Review Boards for oversight of human research came into effect in 1981 following the 1975 revision of the Declaration of Helsinki, and are encapsulated in the 1991 revision to the U.S. Department of Health and Human Services Title 45 CFR 46 (Public Welfare) Subparts A, B, C and D. Subpart A ("The Common Rule") is the baseline standard of ethics by which any government-funded research in the US is held, and nearly all academic institutions hold their researchers to these statements of rights regardless of funding

International Traffic in Arms Regulations (ITAR)

  • Apply to projects that cannot meet the test of research being in the public domain
  • Either publications restrictions or limitations on access or dissemination of research results removes from "fundamental research"
  • In such cases, license from Dept of Commerce (EAR) or Dept of State (ITAR) required to ship technologies out of the country or in some instances allow access to persons who are not US citizens or permanent residents. 

Biosafety Biological Hazards

  • Microorganisms
  • Recombinant DNA (rDNA)
  • CDC List of Select Agents and Toxins
  • Genetically Engineered Organisms and Products
Biosafety Recombinant DNA
  • Guidelines for Research Involving Recombinant DNA Molecules
  • Five-person Institutional Biosafety Committee for review and approval
  • Nature of the research defines the level of review and containment required
  • Nonexempt research requires registration.

Select Agents and Toxins
  • Applies to ALL use of identified agents/toxins and is applicable both to individuals and entities
  • Between Feb 7,2003 and March 12, 2004, entities
    • designated a responsible official (RO)
    • developed
      • a safety plan and laboratory compliance program
      • an emergency response plan
      • a security risk assessment
      • a record management system
      • a theft, loss, or release notification procedure
    • acknowledged the criminal & civil penalties for violation

Radiation Safety
  • Only licensed use of radiation sources, radioisotopes, radiolabeled compounds
  • Regulated by the Nuclear Regulatory Commission
  • Radiation Safety Committee reviews use and protocols
  • Training required

Hazardous Materials
  • Statutory Basis
    • Sections 103 and 107 of the Contract Work Hours & Safety Standard Act (40 USC 327-330), supplemented by DOL regs at 28 CFR, Part 5
    • FAR, Subpart 23.3
    • OMB Circular A-110, Subpart D, Appendix A
  • Applicability
    • All awards over $2000 for construction
    • All awards over $2500 for other activities
  • Requires
    • Notification to employees
    • Preparation & submission of a material safety data sheet

Chemical Safety CSHA Lab Standard
  • Affects all facilities using hazardous chemicals (even those using small quantities)
  • Institutional Chemical Hygiene Plan must minimize employee exposure
  • Information and training
  • Medical exam for person showing symptoms of chemical exposure

Sample Questions:
1. Standards for handling radioactive materials are developed and  monitored by the
a. Nuclear Regulatory Commission.
b. Environmental Protection Agency.
c. Centers for Disease Control and Prevention
d. Occupational Safety  and Health Administration.
 
2.  Which of the following is mandated for the oversight of research involving recombinant DNA?
a. rDNA Committee
b. Biosafety Ethics Committee
c. Institutional Biosafety Committee
d. Institutional Biohazard committee
 
3. Which of the following best describes essential laboratory biosafety levels in medical research?
a. Biosafety cabinets class I, II, or III according to the agent under study
b. Basic and containment procedures designed to protect personnel and the environment
c. Special microbiological practices used to conduct procedures with high aerosol potential
d. Degrees of protection provided to personnel, environment, and community
 
4. Which of the following is essential to a Chemical Hygiene Plan?
a. Material Safety Data Sheet (MSDS) file
b. Monthly fire and safety drills
c. Public information program
d. Federal Food and Dru Administration inspection

 
Answers:
1. a; 2. c; 3. a; 4. a.

Investigational New Drug Studies

  • Food and Drug Administration (FDA-HHS)
  • Governed by 21 CFR 312
  • IND application must be submitted by sponsor to the FDA
  • No clinical investigations prior to FDA approval 
  • Required annual reports regarding the study

Sunday, May 6, 2012

The Belmont Report



Attempts to summarize the basic ethical principles of human subject research.  February 1976.

Objective: To provide an analytical framework that will guide the resolution of ethical problems arising from research involving human subjects.

Practice: Designed solely to enhance the well-being of an individual patient or client and that have a reasonable expectation of success.  Behavioral practice: To provide diagnosis, preventive treatment or therapy to particular individuals. 

Research: designates an activity designed to test an hypothesis, permit conclusions to be drawn, and thereby to develop or contribute to generalizable knowledge.  Research is usually described in a formal protocol that sets forth an objective and a set of procedures designed to reach that objective.

When a clinician departs in a significant way from standard oar accepted practice, the innovation does not , in and of itself, constitute research.  The fact that a procedure is “experimental,” in the sense of new, untested or different, does not automatically place it in the category fo research.  Research and practice may be carried on together when research is designed to evaluate the safety and efficacy of a therapy.

Basic Ethical Principles:
1.      Respect for Persons.
a.       Individuals should be treated as autonomous agents
b.      Persons with diminished autonomy are entitled to protections.
2.      Beneficence.
a.       Do not harm: one should not injure one person regardless of the benefits that might come to others.
b.      Maximize possible benefits and minimize possible harms
                                                              i.      Physicians are required to benefit their patients “according to their best judgment.”
3.      Justice.
a.       To each person an equal share
b.      To each according to individual need
c.       To each according to individual effort
d.      To each according to societal contribution
e.       To each according to merit

Applications:
1.      Informed Consent. Respect for person requires that subjects be given the opportunity to choose what shall or shall not happen to them. This opportunity is provided when adequate standards for informed consent are satisfied.
a.       Information
                                                              i.      Disclosure; sufficient information
1.      Research procedure
2.      Purposes
3.      Risks
4.      Anticipated benefits
5.      Alternative procedures (where therapy is involved)
6.      Statement offering the subject the opportunity to ask questions and to withdraw at any time.
7.      The subject should understand clearly the range of risk and the voluntary nature of participation.
                                                            ii.      When informing subjects of some pertinent information of the research is  likely to impair the validity of:
1.      Incomplete disclosure is truly necessary to accomplish the goals of the research,
2.      There are no undisclosed risks to subjects that are more than minimal
3.      There is an adequate plan for debriefing subjects, when appropriate, and for dissemination of research results to them.
b.      Comprehension
                                                              i.      Necessary to adapt the presentation of the information to the subject’s capacities. (on occasion, it may be suitable to give some oral or written tests of comprehension.)
                                                            ii.      Special provisions may need to be made when comprehension is severely limited (e.g. immaturity or mental disability)
1.      Respect for persons also requires seeking the permission of other parties in order to protect the subjects from harm. Such persons are thus respected both by acknowledging their own wishes and by the use of third parties to protect them from harm.
c.       Voluntariness:
                                                              i.      Free of coercion
1.      Coercion occurs when an overt threat of harm is intentionally presented by one person to another in order to obtain compliance.
                                                            ii.      Free of undue influence
1.      Under influence occurs through as offer of an excessive, unwarranted, inappropriate or improper reward or other overture in order to obtain compliance. 
2.      Also, Inducements that would ordinarily be acceptable may become undue influences if the subject is especially vulnerable.
2.      Assessment of Risks and Benefits:
a.       For the investigator, it is a means to examine whether the proposed research is properly designed.
b.      For a review committee, it is a method for determining whether the risks that will be presented to subjects are justified.
c.       For prospective subjects, the assessment will assist the determination whether or not to participate.
d.      Previous codes and Federal regulations have required that risks to subjects be outweighed by the sum of both the anticipated benefit to the subject, if any, and the anticipated benefit to society in the form of knowledge to be gained from the research.  In balancing these different elements, the risks and benefits affecting the immediate research subject will normally carry special weight.  On the other hand, interests other than those of the subject may on some occasions be sufficient by themselves to justify the risks involved in the research, so long as the subjects’ rights have been protected.  Beneficence thus requires that we protect against risk of harm to subjects and also that we be concerned about the loss of substantial benefits that might be gained from research.
e.       Procedure of assessment:
                                                              i.      Determination of the validity of the presuppositions of the research
                                                            ii.      The nature, probability and magnitude of risk should be distinguished with as much clarity as possible.
                                                          iii.      The method of ascertaining risks should be explicit, especially where there is no alternative to the use of such vague categories as small or slight risk.
                                                          iv.      It should also be determined whether an investigator’s estimates of the probability of harm or benefits are reasonable, as judged by known facts or other available studies.
f.       Justifiability:
                                                              i.      Brutal or inhumane treatment of human subjects is never morally justified
                                                            ii.      Risks should be reduced to those necessary to achieve the research objective.  It should be determined whether it is in fact necessary to use human subjects at all.  Risk can perhaps never be entirely eliminated, but it can often be reduced by careful attention to alternative procedures.
                                                          iii.      When research involves significant risk of serious impairment, review committees should be extraordinarily insistent on the justification of the risk (looking usually to the likelihood of benefit to the subject – or, in some rare cases, to the manifest voluntariness of the participating.
                                                          iv.      When vulnerable populations are involved in research, the appropriateness of involving them should itself be demonstrated. A number of variables go into such judgments, including the nature and degree of risk, the condition of the particular population involved, and the nature and level of the anticipated benefits. 
                                                            v.      Relevant risks and benefits must be thoroughly arrayed in documents and procedures used in the informed consent process.
3.      Selection of subjects:
a.       Individual justice: selection must exhibit fairness: They should not offer potentially beneficial research only to some patients who are in their favor or select only “undesirable” persons for risky research.
b.      Social justice: requires that distinction be drawn between classes of subjects that ought, and ought not, to participate in any particular kind of research, based on the ability of members of that class to bear burdens and on the appropriateness of placing further burdens on already burdened persons. 
c.       Thus, it can be considered a matter of social justice that there is an order of preference in the selection of classes of subjects (e.g., adults before children) and that some clases of potential subjects (e.g., the institutionalized mentally infirm or prisoners) may be involved as research subjects, if at all, only on certain conditions.